IL HB5529

Amends the Wholesale Drug Distribution Licensing Act by adding Section 57.5 to establish general pedigree requirements for prescription drugs.

Requires each prescription drug manufactured to have a Drug Identification Number (DIN) assigned by the manufacturer consisting of Arabic numbers and Roman letters for pedigree transaction identification.

Mandates the DIN include components of the FDA's National Directory Code (drug identification, strength, package size, manufacturer), followed by an Employer Identification Number (EIN), date of receipt, and transfer information for each party handling the inventory.

Requires the DIN to be appended and modified with EIN and data as the drug moves through the supply chain, with each party documenting the updated DIN on transfer documents.

Specifies that no two drug lots manufactured within a 30-year period shall have identical DINs, and the DIN must appear clearly and indelibly on drug packaging or a permanently affixed label.